← All trials
NCT06221345
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 7, 2021
- Primary completion
- Jul 5, 2023
- Completion date
- Jul 5, 2023
- First posted
- Jan 24, 2024
- Last posted
- Jan 24, 2024
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chang Gung UniversityLead sponsor
- Chang Gung UniversitySponsor investigator
- Chang Gung UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.